Mitchell Goldman

9.4k total citations · 3 hit papers
97 papers, 5.7k citations indexed

About

Mitchell Goldman is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Mitchell Goldman has authored 97 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Physiology, 46 papers in Pulmonary and Respiratory Medicine and 25 papers in Epidemiology. Recurrent topics in Mitchell Goldman's work include Asthma and respiratory diseases (41 papers), Respiratory and Cough-Related Research (23 papers) and Inhalation and Respiratory Drug Delivery (21 papers). Mitchell Goldman is often cited by papers focused on Asthma and respiratory diseases (41 papers), Respiratory and Cough-Related Research (23 papers) and Inhalation and Respiratory Drug Delivery (21 papers). Mitchell Goldman collaborates with scholars based in United States, Canada and United Kingdom. Mitchell Goldman's co-authors include Peter Barker, Stephanie Sproule, Eugene R. Bleecker, J. Mark FitzGerald, Magnus Aurivillius, Viktoría Werkström, Geoffrey Gilmartin, Parameswaran Nair, Paul Newbold and Alberto Papi and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Annals of Internal Medicine.

In The Last Decade

Mitchell Goldman

96 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial

2016 984 citations Ken Ohta, Gary T. Ferguson et al. profile →
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial

2016 976 citations Magnus Aurivillius, Mitchell Goldman et al. profile →
Oral Glucocorticoid–Sparing Effect of Benralizumab in Severe Asthma

2017 716 citations Mitchell Goldman et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mitchell Goldman United States	29	4.0k	3.4k	921	897	847	97	5.7k
Isabelle Tillie‐Leblond France	38	2.0k 0.5×	2.3k 0.7×	592 0.6×	355 0.4×	512 0.6×	121	4.4k
Pranabashis Haldar United Kingdom	22	3.2k 0.8×	2.5k 0.7×	475 0.5×	756 0.8×	588 0.7×	67	4.4k
Tatiana Kebadze United Kingdom	27	2.3k 0.6×	1.9k 0.6×	1.9k 2.0×	196 0.2×	302 0.4×	44	4.3k
Olof Selroos Finland	35	4.5k 1.1×	4.2k 1.3×	463 0.5×	352 0.4×	304 0.4×	135	5.5k
Huan‐Zhong Shi China	37	603 0.2×	2.0k 0.6×	532 0.6×	646 0.7×	177 0.2×	121	4.9k
Simon Message United Kingdom	21	1.8k 0.4×	1.6k 0.5×	1.5k 1.7×	176 0.2×	217 0.3×	34	3.8k
Dennis K. Ledford United States	31	1.4k 0.4×	692 0.2×	234 0.3×	434 0.5×	2.0k 2.3×	116	3.9k
Susan L. Hill United Kingdom	29	627 0.2×	2.1k 0.6×	487 0.5×	1.1k 1.3×	61 0.1×	50	3.9k
Paolo Spagnolo Italy	45	2.2k 0.6×	4.7k 1.4×	917 1.0×	369 0.4×	29 0.0×	179	6.2k
Conor M. Burke United States	21	792 0.2×	1.4k 0.4×	399 0.4×	832 0.9×	93 0.1×	41	2.9k

Countries citing papers authored by Mitchell Goldman

Since Specialization

Citations

This map shows the geographic impact of Mitchell Goldman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell Goldman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell Goldman more than expected).

Fields of papers citing papers by Mitchell Goldman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitchell Goldman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell Goldman. The network helps show where Mitchell Goldman may publish in the future.

Co-authorship network of co-authors of Mitchell Goldman

This figure shows the co-authorship network connecting the top 25 collaborators of Mitchell Goldman. A scholar is included among the top collaborators of Mitchell Goldman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitchell Goldman. Mitchell Goldman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Byrne, Barry J., Giancarlo Parenti, Benedikt Schoser, et al.. (2024). Cipaglucosidase alfa plus miglustat: linking mechanism of action to clinical outcomes in late-onset Pompe disease. Frontiers in Neurology. 15. 1451512–1451512. 6 indexed citations

Byrne, Barry J., Benedikt Schoser, Priya S. Kishnani, et al.. (2023). Long-term safety and efficacy of cipaglucosidase alfa plus miglustat in individuals living with Pompe disease: an open-label phase I/II study (ATB200-02). Journal of Neurology. 271(4). 1787–1801. 14 indexed citations

Kraft, Monica, Guy Brusselle, J. Mark FitzGerald, et al.. (2021). Patient characteristics, biomarkers and exacerbation risk in severe, uncontrolled asthma. European Respiratory Journal. 58(6). 2100413–2100413. 43 indexed citations

King, Jennifer, et al.. (2021). Innovation in Resident Core Oncology Education: Switching from an Inpatient Ward Rotation to a Hybrid Model of Inpatient Consultations and Outpatient Clinics. Journal of Cancer Education. 37(6). 1768–1772. 1 indexed citations

Ferguson, Gary T., Adel Mansur, Joshua Jacobs, et al.. (2018). Assessment of an accessorized pre-filled syringe for home-administered benralizumab in severe asthma. Journal of Asthma and Allergy. Volume 11. 63–72. 23 indexed citations

Zeitlin, Pamela L., Mila A. Leong, Jeremy Cole, et al.. (2018). Benralizumab does not impair antibody response to seasonal influenza vaccination in adolescent and young adult patients with moderate to severe asthma: results from the Phase IIIb ALIZE trial. Journal of Asthma and Allergy. Volume 11. 181–192. 28 indexed citations

FitzGerald, J Mark, Ken Ohta, Mitsuru Adachi, et al.. (2017). Benralizumab Reduces Exacerbations in Japanese Patients with Severe, Uncontrolled Asthma: Subgroup Analysis of the Calima Trial. Journal of Allergy and Clinical Immunology. 139(2). AB10–AB10. 1 indexed citations

Goldman, Mitchell, et al.. (2017). Thrombocytopenia and disseminated histoplasmosis in immunocompetent adults. Clinical Case Reports. 5(12). 1954–1960. 4 indexed citations

Mannino, David M., Ruth Tal‐Singer, David A. Lomas, et al.. (2014). Plasma Fibrinogen as a Biomarker for Mortality and Hospitalized Exacerbations in People with COPD. Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation. 2(1). 23–34. 76 indexed citations

10.

Gupta, Samir K., Changyu Shen, Sharon M. Moe, et al.. (2012). Worsening Endothelial Function with Efavirenz Compared to Protease Inhibitors: A 12-Month Prospective Study. PLoS ONE. 7(9). e45716–e45716. 34 indexed citations

11.

Sharafkhaneh, Amir, John G. Southard, Mitchell Goldman, Tom Uryniak, & Ubaldo J. Martin. (2011). Effect of budesonide/formoterol pMDI on COPD exacerbations: A double-blind, randomized study. Respiratory Medicine. 106(2). 257–268. 120 indexed citations

12.

Hage, Chadi A., Timothy E. Stump, Carol A. Kauffman, et al.. (2011). Histoplasma Antigen Clearance during Treatment of Histoplasmosis in Patients with AIDS Determined by a Quantitative Antigen Enzyme Immunoassay. Clinical and Vaccine Immunology. 18(4). 661–666. 49 indexed citations

13.

Shah, Shailen, et al.. (2008). Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patients. Journal of Allergy and Clinical Immunology. 121(6). 1407–1414.e6. 43 indexed citations

14.

Chrousos, George P., et al.. (2007). Basal and Cosyntropin-Stimulated Plasma Cortisol Concentrations, as Measured by High-Performance Liquid Chromatography, in Children Aged 5 Months to Younger than 6 Years. The Journal of Clinical Endocrinology & Metabolism. 92(6). 2125–2129. 6 indexed citations

15.

Markowitz, Martin, Leonard N. Slater, Robert A. Schwartz, et al.. (2007). Long-Term Efficacy and Safety of Tipranavir Boosted With Ritonavir in HIV-1-Infected Patients Failing Multiple Protease Inhibitor Regimens. JAIDS Journal of Acquired Immune Deficiency Syndromes. 45(4). 401–410. 16 indexed citations

16.

Wheat, L. Joseph, Gretchen A. Cloud, Philip C. Johnson, et al.. (2001). Clearance of Fungal Burden during Treatment of Disseminated Histoplasmosis with Liposomal Amphotericin B versus Itraconazole. Antimicrobial Agents and Chemotherapy. 45(8). 2354–2357. 63 indexed citations

17.

Cummings, Oscar W., et al.. (1999). BACILLARY ANGIOMATOSIS IN A RENAL TRANSPLANT RECIPIENT. Transplantation. 67(2). 296–298. 19 indexed citations

18.

McKinsey, David S., L. Joseph Wheat, Gretchen A. Cloud, et al.. (1999). Itraconazole Prophylaxis for Fungal Infections in Patients with Advanced Human Immunodeficiency Virus Infection: Randomized, Placebo‐Controlled, Double‐Blind Study. Clinical Infectious Diseases. 28(5). 1049–1056. 106 indexed citations

19.

Goldman, Mitchell, et al.. (1998). Central Nervous System Infections Due toStomatococcus mucilaginosusin Immunocompromised Hosts. Clinical Infectious Diseases. 27(5). 1241–1246. 21 indexed citations

20.

Pizzarello, Roy A., Mitchell Goldman, James Fetten, et al.. (1985). Tumor of the heart diagnosed by magnetic resonance imaging. Journal of the American College of Cardiology. 5(4). 989–991. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact